Comprehensive, easy-to-understand information about this condition
How we create this content →Documentation for autosomal recessive spastic paraplegia type 60 is limited due to its extreme rarity, affecting fewer than 1 in 1,000,000 individuals. This rarity restricts the number of systematic clinical studies, making it challenging to gather comprehensive data. Furthermore, the lack of identified genes and established inheritance patterns complicates understanding the condition's etiology and clinical progression. As research continues, there is hope that more information will become available.
The clinical picture of autosomal recessive spastic paraplegia type 60 includes several key features. Limb hypertonia and spastic paraplegia are prominent, affecting mobility and muscle tone. Motor axonal neuropathy can lead to weakness and sensory deficits. Additionally, nystagmus may affect vision, while mild intellectual disability can impact cognitive function. Lower limb spasticity and gait disturbances are common, contributing to difficulties in movement. These symptoms can significantly affect daily life and require comprehensive management.
To navigate your care for autosomal recessive spastic paraplegia type 60, consider seeking a neurologist with expertise in hereditary spastic paraplegias. They can provide tailored management strategies and support. While there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov. Additionally, consider genetic counseling, which may provide insights into familial implications and support options. Although research is limited, staying connected with healthcare providers can help you stay informed about any emerging studies or resources.
Actionable guidance for navigating care for autosomal recessive spastic paraplegia type 60
To navigate your care for autosomal recessive spastic paraplegia type 60, consider seeking a neurologist with expertise in hereditary spastic paraplegias. They can provide tailored management strategies and support. While there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov. Additionally, consider genetic counseling, which may provide insights into familial implications and support options. Although research is limited, staying connected with healthcare providers can help you stay informed about any emerging studies or resources.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for autosomal recessive spastic paraplegia type 60 is limited due to its extreme rarity, affecting fewer than 1 in 1,000,000 individuals. This rarity restricts the number of systematic clinical studies, making it challenging to gather comprehensive data. Furthermore, the lack of identified genes and established inheritance patterns complicates understanding the condition's etiology and clinical progression. As research continues, there is hope that more information will become available.
The clinical picture of autosomal recessive spastic paraplegia type 60 includes several key features. Limb hypertonia and spastic paraplegia are prominent, affecting mobility and muscle tone. Motor axonal neuropathy can lead to weakness and sensory deficits. Additionally, nystagmus may affect vision, while mild intellectual disability can impact cognitive function. Lower limb spasticity and gait disturbances are common, contributing to difficulties in movement. These symptoms can significantly affect daily life and require comprehensive management.
To navigate your care for autosomal recessive spastic paraplegia type 60, consider seeking a neurologist with expertise in hereditary spastic paraplegias. They can provide tailored management strategies and support. While there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov. Additionally, consider genetic counseling, which may provide insights into familial implications and support options. Although research is limited, staying connected with healthcare providers can help you stay informed about any emerging studies or resources.
Actionable guidance for navigating care for autosomal recessive spastic paraplegia type 60
To navigate your care for autosomal recessive spastic paraplegia type 60, consider seeking a neurologist with expertise in hereditary spastic paraplegias. They can provide tailored management strategies and support. While there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov. Additionally, consider genetic counseling, which may provide insights into familial implications and support options. Although research is limited, staying connected with healthcare providers can help you stay informed about any emerging studies or resources.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Documentation for autosomal recessive spastic paraplegia type 60 is limited due to its extreme rarity, affecting fewer than 1 in 1,000,000 individuals. This rarity restricts the number of systematic clinical studies, making it challenging to gather comprehensive data. Furthermore, the lack of identified genes and established inheritance patterns complicates understanding the condition's etiology and clinical progression. As research continues, there is hope that more information will become available.
The clinical picture of autosomal recessive spastic paraplegia type 60 includes several key features. Limb hypertonia and spastic paraplegia are prominent, affecting mobility and muscle tone. Motor axonal neuropathy can lead to weakness and sensory deficits. Additionally, nystagmus may affect vision, while mild intellectual disability can impact cognitive function. Lower limb spasticity and gait disturbances are common, contributing to difficulties in movement. These symptoms can significantly affect daily life and require comprehensive management.
To navigate your care for autosomal recessive spastic paraplegia type 60, consider seeking a neurologist with expertise in hereditary spastic paraplegias. They can provide tailored management strategies and support. While there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov. Additionally, consider genetic counseling, which may provide insights into familial implications and support options. Although research is limited, staying connected with healthcare providers can help you stay informed about any emerging studies or resources.
Actionable guidance for navigating care for autosomal recessive spastic paraplegia type 60
To navigate your care for autosomal recessive spastic paraplegia type 60, consider seeking a neurologist with expertise in hereditary spastic paraplegias. They can provide tailored management strategies and support. While there are currently no identified patient organizations, you can find resources through the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov. Additionally, consider genetic counseling, which may provide insights into familial implications and support options. Although research is limited, staying connected with healthcare providers can help you stay informed about any emerging studies or resources.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.